• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correspondence: Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer.

作者信息

Akdoğan Orhun, Sütcüoğlu Osman, Özet Ahmet, Yazıcı Ozan, Özdemir Nuriye

机构信息

Department of Medical Oncology, Gazi University, Ankara, Turkey.

出版信息

Support Care Cancer. 2023 Aug 1;31(8):500. doi: 10.1007/s00520-023-07969-z.

DOI:10.1007/s00520-023-07969-z
PMID:37526795
Abstract
摘要

相似文献

1
Correspondence: Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer.通信：全长生长分化因子-15在晚期非小细胞肺癌恶病质中的局部表达意义
Support Care Cancer. 2023 Aug 1;31(8):500. doi: 10.1007/s00520-023-07969-z.
2
Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer.全长生长分化因子-15在晚期非小细胞肺癌恶病质中的局部表达意义
Support Care Cancer. 2023 Apr 28;31(5):308. doi: 10.1007/s00520-023-07771-x.
3
Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndrome.厄洛替尼联合肠外营养：应对晚期非小细胞肺癌伴癌症恶病质综合征最艰难日子的契机。
Am J Hosp Palliat Care. 2013 Mar;30(2):210-3. doi: 10.1177/1049909113476930. Epub 2013 Feb 6.
4
Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).厌食-恶病质治疗功能评估（FAACT）量表在晚期非小细胞肺癌患者及癌症厌食-恶病质综合征（CACS）中的验证及真实世界评估
Support Care Cancer. 2015 Aug;23(8):2341-7. doi: 10.1007/s00520-015-2606-z. Epub 2015 Jan 14.
5
Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.晚期非小细胞肺癌患者癌性恶病质的生活质量与生存调查——日本晚期非小细胞肺癌患者营养与生活质量调查研究
Support Care Cancer. 2016 Aug;24(8):3473-80. doi: 10.1007/s00520-016-3156-8. Epub 2016 Mar 22.
6
Anthropometric measurements in non-small-cell lung cancer.非小细胞肺癌的人体测量学指标
Support Care Cancer. 2002 Jul;10(5):439; author reply 440. doi: 10.1007/s00520-001-0327-y.
7
Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.非小细胞肺癌恶病质患者FACIT疲劳量表和FAACT分量表的简短版本。
Support Care Cancer. 2015 May;23(5):1355-64. doi: 10.1007/s00520-014-2484-9. Epub 2014 Oct 29.
8
[Cancer cachexia syndrome in patients with lung cancer].[肺癌患者的癌症恶病质综合征]
Wiad Lek. 2003;56(7-8):308-12.
9
Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss.在非自愿性体重减轻的肺癌患者中，对厌食/恶病质治疗功能性评估（FAACT）厌食/恶病质量表（A/CS）进行全面验证。
Qual Life Res. 2019 Jun;28(6):1641-1653. doi: 10.1007/s11136-019-02135-7. Epub 2019 Feb 22.
10
Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis.阿那莫林治疗伴有恶液质的晚期非小细胞肺癌的系统评价和荟萃分析。
Lung Cancer. 2017 Oct;112:25-34. doi: 10.1016/j.lungcan.2017.07.023. Epub 2017 Jul 27.

本文引用的文献

1
Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer.全长生长分化因子-15在晚期非小细胞肺癌恶病质中的局部表达意义
Support Care Cancer. 2023 Apr 28;31(5):308. doi: 10.1007/s00520-023-07771-x.
2
The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker.细胞因子生长分化因子-15 与骨骼肌健康：新兴的广泛适用疾病生物标志物画像。
Int J Mol Sci. 2022 Oct 29;23(21):13180. doi: 10.3390/ijms232113180.
3
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.
2021 年世卫组织肺肿瘤分类：自 2015 年以来的进展影响。
J Thorac Oncol. 2022 Mar;17(3):362-387. doi: 10.1016/j.jtho.2021.11.003. Epub 2021 Nov 20.
4
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.奥希替尼治疗未经治疗的 EGFR 突变型晚期非小细胞肺癌。
N Engl J Med. 2018 Jan 11;378(2):113-125. doi: 10.1056/NEJMoa1713137. Epub 2017 Nov 18.
5
Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients.血浆生长分化因子15与癌症患者的体重减轻和死亡率相关。
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):317-24. doi: 10.1002/jcsm.12033. Epub 2015 Apr 30.
6
Definition and classification of cancer cachexia: an international consensus.癌症恶病质的定义和分类：国际共识。
Lancet Oncol. 2011 May;12(5):489-95. doi: 10.1016/S1470-2045(10)70218-7. Epub 2011 Feb 4.
7
Cachexia: a new definition.恶病质：一个新定义。
Clin Nutr. 2008 Dec;27(6):793-9. doi: 10.1016/j.clnu.2008.06.013. Epub 2008 Aug 21.